Yaroslavl Regional Clinical Hospital for Military Veterans Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03638830
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Yaroslavl Regional Clinical Hospital for Military Veterans | Yaroslavl Regional Clinical Hospital for War Veterans - The International Center for the Elderly "Healthy Longevity" | Yaroslavl State Institution of Healthcare "Clinical Hospital No. 3" II stage

Active Ingredients

Drugs in Phase 3 Trials (1)

molixan (1 trial)

Drugs in Phase 2 Trials (2)

cefepime (maxipeme) (1 trial)

fluticasone (cutivate) (1 trial)

Drugs in Other Trials (1)

Molnupiravir (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Pseudomonas Infections (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4